Examining BRITEpath , a Digital Intervention for Reducing Adolescent Suicide Risk in Primary Care: A Randomized‐Controlled Trial
Suicide and Life-Threatening Behavior · 2026
DOI: 10.1111/sltb.70114 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Suicide and Life-Threatening Behavior, 2026. Verfasst von Nermin Toukhy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Suicidal Ideation, Suicide Prevention, Mobile Applications. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Pittsburgh, NIMH NIH HHS, Israel Science Foundation.
Abstract (Originalsprache)
Introduction
Previous research has identified a high need for suicide risk management in primary care settings among adolescents. This randomized controlled trial examined the efficacy and feasibility of BRITEpath, a smartphone‐based application and clinician portal designed to help youth in reducing suicide risk.
Methods
Participants ( n = 101, ages 12–26, 85.1% female) that were either referred to or were receiving mental health services in primary care were randomly assigned (2:1 allocation) to BRITEpath + TAU ( n = 68) or TAU alone ( n = 33). Independent evaluators, blinded to treatment, assessed outcomes at baseline, Week 4, and Week 12. Primary outcomes included suicidal thoughts and behaviors, depression, mental health service use, and quality of life; secondary outcomes examined usability and satisfaction.
Results
No significant differences were found between BRITEpath + TAU and TAU for primary outcomes overall. However, BRITEpath participants reported lower suicidal thoughts over time. History of inpatient and outpatient care moderated the effect of BRITEpath on depression. Participants reported high satisfaction and perceived usefulness of the app.
Conclusions
BRITEpath shows promising effects on suicidal thoughts and depression, particularly among those with prior psychiatric care. Future research should explore strategies to enhance engagement, such as integration with ongoing care, which may strengthen the impact on clinical outcomes. Trial Registration ClinicalTrials.gov identifier: NCT04672798
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Western Psychiatric Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Nermin Toukhy, Candice Biernesser, David Brent
Förderung
- University of Pittsburgh
- NIMH NIH HHS
- Israel Science Foundation
- Fulbright U.S. Scholar Program
- National Institute of Mental Health
Zitieren
APA
Toukhy, N., Biernesser, C., Zelazny, J., George-Milford, B., Monteverde, C., Porta, G., Abebe, K. Z., Brent, D., & Stepp, S. (2026). Examining BRITEpath , a Digital Intervention for Reducing Adolescent Suicide Risk in Primary Care: A Randomized‐Controlled Trial. Suicide and Life-Threatening Behavior. https://doi.org/10.1111/sltb.70114
Vancouver
Toukhy N, Biernesser C, Zelazny J, George-Milford B, Monteverde C, Porta G, et al. Examining BRITEpath , a Digital Intervention for Reducing Adolescent Suicide Risk in Primary Care: A Randomized‐Controlled Trial. Suicide and Life-Threatening Behavior. 2026. doi:10.1111/sltb.70114
BibTeX
@article{Toukhy2026,
author = {Toukhy, Nermin and Biernesser, Candice and Zelazny, Jamie and George-Milford, Brandie and Monteverde, Casey and Porta, Giovanna and Abebe, Kaleab Z and Brent, David and Stepp, Stephanie},
title = {Examining BRITEpath , a Digital Intervention for Reducing Adolescent Suicide Risk in Primary Care: A Randomized‐Controlled Trial},
journal = {Suicide and Life-Threatening Behavior},
year = {2026},
doi = {10.1111/sltb.70114}
}
EUVIMED